Business Description
Labiana Health SA
ISIN : ES0105638003
Total Employee Number:
401Compare
Compare
Traded in other countries / regions
LAB.Spain8RK.Germany IPO Date
2022-07-01Description
Labiana Health SA is a manufacturer of pharmacological products for veterinary use. The company's activities include a GMP manufacturer for EU animal and human health industries, a manufacturer specializing in sterile and lyophilized dosage forms, and a source of development, acquisition, and licensing of molecules such as Fosfomycin Trometamol. The company operates in two segment Animal Health and Human Health.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.16 | |||||
Equity-to-Asset | 0.09 | |||||
Debt-to-Equity | 7.21 | |||||
Debt-to-EBITDA | 3.37 | |||||
Interest Coverage | 1.24 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 2.61 | |||||
Beneish M-Score | -2.28 | |||||
WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 10.1 | |||||
3-Year FCF Growth Rate | -53.8 | |||||
3-Year Book Growth Rate | -9.5 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 36.74 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 7.59 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 46.13 | |||||
9-Day RSI | 49.12 | |||||
14-Day RSI | 49.85 | |||||
3-1 Month Momentum % | 41.11 | |||||
6-1 Month Momentum % | 41.57 | |||||
12-1 Month Momentum % | 78.54 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.39 | |||||
Quick Ratio | 0.86 | |||||
Cash Ratio | 0.26 | |||||
Days Inventory | 143.09 | |||||
Days Sales Outstanding | 52.05 | |||||
Days Payable | 124.17 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | 0.9 | |||||
Shareholder Yield % | -2.76 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 61.15 | |||||
Operating Margin % | 9.71 | |||||
Net Margin % | 3.42 | |||||
EBITDA Margin % | 14.5 | |||||
FCF Margin % | -3.64 | |||||
OCF Margin % | 2.26 | |||||
ROE % | 64.9 | |||||
ROA % | 4.7 | |||||
ROIC % | 20.43 | |||||
3-Year ROIIC % | -62.4 | |||||
ROC (Joel Greenblatt) % | 30.9 | |||||
ROCE % | 21.98 | |||||
Years of Profitability over Past 10-Year | 3 |
GF Value Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 19.03 | |||||
Forward PE Ratio | 7.96 | |||||
PE Ratio without NRI | 18.41 | |||||
Price-to-Owner-Earnings | 69.79 | |||||
PS Ratio | 0.65 | |||||
PB Ratio | 9.45 | |||||
Price-to-Operating-Cash-Flow | 28.03 | |||||
EV-to-EBIT | 12.23 | |||||
EV-to-Forward-EBIT | 11.18 | |||||
EV-to-EBITDA | 7.97 | |||||
EV-to-Forward-EBITDA | 8.23 | |||||
EV-to-Revenue | 1.15 | |||||
EV-to-Forward-Revenue | 1.07 | |||||
EV-to-FCF | -31.9 | |||||
Price-to-GF-Value | 1.85 | |||||
Earnings Yield (Greenblatt) % | 8.18 | |||||
FCF Yield % | -4.85 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Labiana Health SA Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 75.182 | ||
| EPS (TTM) (€) | 0.352 | ||
| Beta | 1.2192 | ||
| 3-Year Sharpe Ratio | 0.73 | ||
| 3-Year Sortino Ratio | 1.3 | ||
| Volatility % | 64.8 | ||
| 14-Day RSI | 49.85 | ||
| 14-Day ATR (€) | 0.165 | ||
| 20-Day SMA (€) | 6.51 | ||
| 12-1 Month Momentum % | 78.54 | ||
| 52-Week Range (€) | 3.497334 - 7.7 | ||
| Shares Outstanding (Mil) | 8.49 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Labiana Health SA Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Labiana Health SA Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Labiana Health SA Frequently Asked Questions
What is Labiana Health SA(FRA:8RK)'s stock price today?
The current price of FRA:8RK is €6.55. The 52 week high of FRA:8RK is €7.70 and 52 week low is €3.50.
When is next earnings date of Labiana Health SA(FRA:8RK)?
The next earnings date of Labiana Health SA(FRA:8RK) is .
Does Labiana Health SA(FRA:8RK) pay dividends? If so, how much?
Labiana Health SA(FRA:8RK) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Labiana Health SA
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers